Dr. John Buse shares what is new in the treatment of diabetes, and highlights the benefits that SGLT2 inhibitors and GLP-1 receptor agonists can offer to patients, among other topics related to diabetes treatment.
Dr. John Buse shares what is new in the treatment of diabetes, and highlights the benefits that SGLT2 inhibitors and GLP-1 receptor agonists can offer to patients, among other topics related to diabetes treatment.